Search research articles
Contact Us
Filters
Showing results (21-30 of 51) with videos related to
Page
of 6
Sort By:
MMWR. CDC Surveillance Summaries : Morbidity and Mortality Weekly Report. CDC Surveillance Summaries
|
July 17, 1998
Postneonatal mortality surveillance--United States, 1980-1994
C L Scott, S Iyasu, D Rowley, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 1, 1975
Inhibition of L-dopa-induced growth hormone stimulation by pyridoxine and chlorpromazine
R B Mims, C L Scott, O Modebe, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
January 11, 2001
Effect of granulocyte-macrophage colony-stimulating factor on the generation of epidermal Langerhans cells
K Burnham, L Robb, C L Scott, et al.
Biochimica Et Biophysica Acta
|
March 19, 2015
Prioritizing therapeutic targets using patient-derived xenograft models
K A Lodhia, A M Hadley, P Haluska, et al.
Cell Death & Disease
|
May 11, 2012
Neither loss of Bik alone, nor combined loss of Bik and Noxa, accelerate murine lymphoma development or render lymphoma cells resistant to DNA damaging drugs
L Happo, B Phipson, G K Smyth, et al.
Nature
|
December 23, 1982
Amplification of immunoglobulin lambda constant genes in populations of wild mice
C L Scott, J F Mushinski, K Huppi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 1, 1973
Prevention of L-dopa-induced growth hormone stimulation by hyperglycemia
R B Mims, C L Scott, O M Modebe, et al.
ESMO Open
|
November 21, 2022
The impact of single agent PD-1 or PD-L1 inhibition on advanced endometrial cancers: meta-analysis
P-S Kok, Y C Antill, C L Scott, et al.
Cell Death and Differentiation
|
July 9, 2013
How to best preserve oocytes in female cancer patients exposed to DNA damage inducing therapeutics
K Hutt, J B Kerr, C L Scott, et al.
Experimental Hematology
|
September 29, 2000
Granulocyte-macrophage colony-stimulating factor is not responsible for residual thrombopoiesis in mpl null mice
C L Scott, L Robb, R Mansfield, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 51) with videos related to
Sort By:
Page
of 6
MMWR. CDC Surveillance Summaries : Morbidity and Mortality Weekly Report. CDC Surveillance Summaries
|
July 17, 1998
Postneonatal mortality surveillance--United States, 1980-1994
C L Scott, S Iyasu, D Rowley, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 1, 1975
Inhibition of L-dopa-induced growth hormone stimulation by pyridoxine and chlorpromazine
R B Mims, C L Scott, O Modebe, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
January 11, 2001
Effect of granulocyte-macrophage colony-stimulating factor on the generation of epidermal Langerhans cells
K Burnham, L Robb, C L Scott, et al.
Biochimica Et Biophysica Acta
|
March 19, 2015
Prioritizing therapeutic targets using patient-derived xenograft models
K A Lodhia, A M Hadley, P Haluska, et al.
Cell Death & Disease
|
May 11, 2012
Neither loss of Bik alone, nor combined loss of Bik and Noxa, accelerate murine lymphoma development or render lymphoma cells resistant to DNA damaging drugs
L Happo, B Phipson, G K Smyth, et al.
Nature
|
December 23, 1982
Amplification of immunoglobulin lambda constant genes in populations of wild mice
C L Scott, J F Mushinski, K Huppi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 1, 1973
Prevention of L-dopa-induced growth hormone stimulation by hyperglycemia
R B Mims, C L Scott, O M Modebe, et al.
ESMO Open
|
November 21, 2022
The impact of single agent PD-1 or PD-L1 inhibition on advanced endometrial cancers: meta-analysis
P-S Kok, Y C Antill, C L Scott, et al.
Cell Death and Differentiation
|
July 9, 2013
How to best preserve oocytes in female cancer patients exposed to DNA damage inducing therapeutics
K Hutt, J B Kerr, C L Scott, et al.
Experimental Hematology
|
September 29, 2000
Granulocyte-macrophage colony-stimulating factor is not responsible for residual thrombopoiesis in mpl null mice
C L Scott, L Robb, R Mansfield, et al.
Page
of 6